Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement
Posted: 14 November 2024 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce it has entered…
World-first cure for lethal skin disease achieved in landmark study
Posted: 14 November 2024 A team of researchers has for the first time cured patients with a lethal skin disease, in a breakthrough study that could lead to an approved curative therapy for the deadly condition. Toxic epidermal…
Project to pioneer alternatives to steroid treatments receives inaugural Translational Bridge Award from Lupus Research Alliance
Posted: 14 November 2024 Associate Professor Sarah Jones from the School of Clinical Sciences at Monash Health is one of five researchers worldwide and the only Australian researcher to receive an inaugural Translational Bridge Award from the Lupus Research Alliance (LRA) in New…
Ancient gene offers new clue to disease susceptibility for First Nations people
Posted: 6 November 2024 A world-first discovery has identified a previously unknown gene variant influencing first-line immune defences in First Nations people – who are at higher risk of severe respiratory viral diseases – and offers insights for…
Mobile white blood cells “gobble up” Alzheimer’s disease plaque
Posted: 6 November 2024 Florey researchers have made a startling discovery: Monocytes, a type of mobile white blood cell, can help clean up plaque-causing amyloid-beta (Aβ) throughout the body. Aβ accumulates in the brains of people with Alzheimer’s…
Revolutionary high-speed 3D bioprinter hailed a gamechanger for drug discovery
Posted: 6 November 2024 Biomedical engineers from the University of Melbourne have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissue to…
Burnet partners with Atomo to develop Australia’s first syphilis self-test
Posted: 4 November 2024 Burnet Institute is pleased to announce our collaboration with Atomo Diagnostics on an active syphilis point of care test, which has received $2.44 million from the Australian Government. The funding will help drive the…
Cellular couriers: Body’s ‘delivery trucks’ could lead to new cancer blood test
Posted: 31 October 2024 A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies. Extracellular vesicles…
Interim Data from ACCENT Pancreatic Cancer Trial
Posted: 31 October 2024 Amplia Therapeutics has today released interim data from the Company’s Phase 2a clinical trial investigating narmafotinib in the treatment of advanced pancreatic cancer. As previously reported, narmafotinib is generally well tolerated by patients with…
BioMelbourne Network and AusBiotech strengthen collaboration
Posted: 30 October 2024 BioMelbourne Network, Victoria’s leading industry association for organisations engaged in biotechnology, medical technology, and health innovation in Victoria and AusBiotech, Australia’s leading national industry association representing more than 3000 members across the life sciences…
Study may help boost performance and reduce side effects of mRNA vaccines
Posted: 29 October 2024 A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream. The research aimed to…
$55 million to scale up Aussie innovations
Posted: 29 October 2024 The Albanese Government is backing Australian business and science, funding world-leading innovations that can help transform Australian industry. More than $55 million in grants for projects working in critical minerals, renewable energy and other…
